KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Common Equity: 2018-2025

Historic Common Equity for Aurora Cannabis (ACB) over the last 6 years, with Mar 2025 value amounting to $395.3 million.

  • Aurora Cannabis' Common Equity fell 4.85% to $395.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $395.3 million, marking a year-over-year decrease of 4.85%. This contributed to the annual value of $395.3 million for FY2025, which is 4.85% down from last year.
  • According to the latest figures from Q1 2025, Aurora Cannabis' Common Equity is $395.3 million, which was down 9.83% from $438.4 million recorded in Q4 2024.
  • In the past 5 years, Aurora Cannabis' Common Equity registered a high of $1.7 billion during Q1 2021, and its lowest value of $362.9 million during Q1 2023.
  • Its 3-year average for Common Equity is $408.6 million, with a median of $410.0 million in 2023.
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 71.73% in 2022, then climbed by 16.47% in 2024.
  • Quarterly analysis of 5 years shows Aurora Cannabis' Common Equity stood at $1.6 billion in 2021, then plummeted by 71.73% to $438.3 million in 2022, then fell by 6.46% to $410.0 million in 2023, then grew by 6.92% to $438.4 million in 2024, then decreased by 4.85% to $395.3 million in 2025.
  • Its Common Equity stands at $395.3 million for Q1 2025, versus $438.4 million for Q4 2024 and $427.4 million for Q3 2024.